Risks with continuous subcutaneous insulin infusion can be seriousBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7314.693/a (Published 22 September 2001) Cite this as: BMJ 2001;323:693
- G Knight, consultant physician
- Rotherham General Hospitals NHS Trust, Rotherham General Hospital, Rotherham S60 2UD
EDITOR—The editorial by Pickup and Keen about continuous subcutaneous insulin infusion is worrying in advocating this treatment, albeit for a comparatively small proportion of the diabetic population in Britain.1 Pickup and Keen do not highlight adequately the serious risks associated with it for doctors considering introducing this treatment to their patients.
Pickup and Keen acknowledge high rates of ketoacidosis with subcutaneous insulin infusion but attribute it to lack of experience, unsuitable pump insulin, and the less reliable devices previously available. They …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial